Cheah et al. Matrix Biology, vol. 14, p. 409, 1994.* |
Mullins et al. J. Clin. Invest., vol. 98, pp. S37-40, 1996.* |
Moreadith et al. J. Mol. Med., vol. 75, pp. 208-216, 1997.* |
Garofalo et al. PNAS, vol. 88, pp. 9648-9652, 1991.* |
Wall Theriogenology, vol. 45, pp. 57-68, 1996.* |
deCrombrugghe et al. J. Rheumatology, vol. 22, pp. 140-142, 1995.* |
Li et al. Genes and Devel., vol. 9, pp. 2821-2830, 1995.* |
Augee, 1992.* |
Li et al. (Genes & Devel. (Nov. 15, 1995) 9 (22) 2821-30).* |
Cheah et al. (Matrix Biology 14 (5). 1994. 409).* |
Whittington et al. (Nature Genetics, (Feb. 1995) 9 (2) 197-201).* |
Vandenberg et al. (Proc. Natl. Acad. Sci. USA (1991) Sep. 1 88 (17) 7640-4).* |
Dombrowicz et al. (J. Immunol. (Aug. 15, 1996) 157 (4) 1645-51).* |
Lefebvre et al. ( Matrix Biol. (Aug. 1994) 14 (4) 329-35).* |
Rosati et al. (Nature Genetics, Oct. 8, 1994 (2) 129-35).* |
Charreau et al. (Transgenic research, (Jul. 1996) 5 (4) 223-34) (Abstract).* |
NIH Reports, Dec. 1995.* |
Wall R. J. Theriogenology, 45, 57-68, 1996.* |
Houdebine L.-M. J. Biotechnol. 34, 1994, 269-287.* |
Wagner et al. Genetic Engineering: Principles and Methods. 1988, vol. 10, p221-246, (p. 221 and p. 238 Only).* |
Ala-Kokko et al., Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia, (1990) Proc. Natl. Acad. Sci. USA, 87:6565-68. |
Bonadio et al., “Transgenic mouse model of the mild dominant form of osteogenesis imperfecta”, (1990) Proc. Natl. Acad. Sci. USA, 87:7145-49. |
Bradley et al., “Formation of germ-line chimaeras from embryo=derived teratocarcinoma cell lines”, (1984) Nature 309:255-256. |
de Crombrugghe et al., “Transgenic Mice with Deficiencies in Cartilage Collagens: Possible Models for Gene Therapy”, (1995) J. Rheumatol., 22:1 Supp. 43:140-142. |
Drabek et al., Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control region, (1997) Proc. Natl Acad. Sci. USA 94:610. |
Engel and Prockop, “The Zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper”, (1991) Annu. Rev. Biophys. Biophys. Chem. 20:137-52. |
Fleischmaier et al., “Structure, Molecular Biology, and Pathology of Collagen”, (1990) Ann. NY Acad. Sci. 580:161-175. |
Garofalo et al., “Assembly of cartilage collagen fibrils is disrupted by overexpression of normal type II collagen in transgenic mice”, (1993) Proc. Natl. Acad. Sci. USA, 90:3825-29. |
Nakata, et al., “Osteoarthritis associated with mild chondrodysplasia in transgenic mice expression α1 (IX) collagen chains with a central deletion”, (1993) Proc. Natl. Acad. Sci. USA 90:2870. |
Garofalo et al., “Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen α1-chain gene”, (1991) Proc. Natl. Acad. Sci. USA, 88:9648-52. |
Helminen et al., “An Inbred Line of Transgenic Mice Expression an Internally Deleted Gene for Type II Procollagen (COL2A1)”, (1993) J. Clin. Invest., 92:582-95. |
Hulmes, “The collagen superfamily—diverse structures and assemblies”, (1992) Essays Biochem., 27:49-67. |
Kivirikko, “Collagens and their Abnormalities in a Wide Spectrum of Diseases”, (1993) Ann. Med., 25:113-26. |
Kuivaniemi et al., “Mutations in collagen genes: causes of rare and some common diseases in humans”, (1991) FASEB J., 5:2052-60. |
Li et al., “Transgenic mice with targeted inactivation of the Col2a1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone”, (1995) Genes & Development 9:2821-2830. |
Lanza et al., “Encapsulated cell technology”, (1996) Nature Biotechnology 14:1107-1111. |
Maga, E.A. and J.D. Murray, “Mammary Gland Expression of Transgenes and the Potential for Altering the Properties of Milk”, (1995) Biotechnology 13:1452-1456. |
Metsaranta et al., “Chondrodysplasia in Transgenic Mice Harboring a 15-Amino Acid Deletion in the Triple Helical Domain of Proα (II) Collagen Chain”, (1992) J. Cell Biol., 118:203-12. |
Prockop and Kivirikko, “Collagens: Molecular Biology, Diseases, and Potentials for Therapy”, (1995) Annu. Rev. Biochem. 64:403-34. |
Ritvaniemi et al., “Identification of Col2A1 Gene Mutations in Patients with Chondrodysplasias and Familial Osteoarthritis”, (1995) Arthritis Rheum., 38:999-1004. |
Schenkel et al., “Functional rescue of the glomerulosclerosis phenotype in Mpv17 mice by transgenesis with the human Mpv17 homologue”, (1995) Kid. Inter. 48:80. |
Schoonjans et al., “Pluripotential Rabbit Embryonic Stem (ES) Cells Are Capable of Forming Overt Coat Color Chimeras Following Injection Into Blastocysts”, (1996) Molecular Reproduction and Development 45:439-443. |
Spranger et al., “The type II collagenopathies: a spectrum of chondrodysplasias”, (1994) Eur. J. Pediatr., 153:56-65. |
Vandenberg et al., “Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia”, (1991) Proc. Natl. Acad. Sci. USA, 88:7640-44. |
Vikkula et al., “Type II Collagen Mutations in Rare and Common Cartilage Diseases”, (1994) Ann. Med., 26: 107-14. |
Vuorio, E., and de Crombrugghe, B., “The Family of Collagen Genes”, (1990) Ann. Rev. Biochem. 59:837-872. |
Williams et al., “Rapid Detection of Mutations by Conformation-Sensitive Gel Electrophoresis. Application to the Indentification of a Fourth Family with the Arg519-Cys Substitution and Three New Mutations in the Type II Procollagen Gene”, (1994) Matrix Biol., 14:391. |
Wu et al., “Human-Mouse Interspecies Collagen I Heterotrimer Is Functional during Embryonic Development of Mov13 Mutant Mouse Embryos”, (1990) Mol. and Cell Biol., 10:1452-60. |